• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Vector Pharma FZCO Announce Agreement with Ascendis for Skytrofa

    08 Jan 2024 //

    GLOBENEWSWIRE

    TransCon Achieved Superior Outcomes Compared to Placebo in Ph 3 foresiGHt Trial

    19 Dec 2023 //

    GLOBENEWSWIRE

    Ascendis Pharma Launches SKYTROFA in Germany

    15 Sep 2023 //

    GLOBENEWSWIRE

    Ascendis` Biologic Skytrofa (Lonapegsomatropin) Receives Approval in the U.S.

    20 Oct 2022 //

    FDA

    VISEN Pharma`s Top-line Results of PIII Trial of Once-Weekly Lonapegsomatropin

    23 May 2022 //

    PRNEWSWIRE

    Ascendis Pharma to Present New Endocrinology Results at 4 Medical Meetings

    01 May 2022 //

    GLOBENEWSWIRE

    Ascendis Pharma`s Lonapegsomatropin Receives Approval in Europe

    11 Jan 2022 //

    EMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.